Typicality: | 0.387 |
Saliency: | 0.322 |
for liver cancer | 4 | other |
quickly | 2 | manner |
after passing the mouse model stage | 2 | temporal |
compound → be tested in → human | 8 |
compound → be tested on → human | 4 |
compound → be tested in → patient | 3 |
negative | neutral | positive |
0.072 | 0.688 | 0.240 |
Raw frequency | 15 |
Normalized frequency | 0.322 |
Modifier score | 0.500 |
Perplexity | 64.628 |